- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02032069
Pneumoproteins Expression in the Organ Donor
March 13, 2016 updated by: Asmae Belhaj, University Hospital of Mont-Godinne
Primary graft dysfunction, a form of reperfusion pulmonary edema that occurs early after lung transplantation, shares key clinical and pathological features with acute lung injury and its more severe form, the acute respiratory distress syndrome.
However, in contrast to acute lung injury/acute respiratory distress syndrome, in which biomarkers in plasma, urine and lung edema fluid have prognostic and pathogenetic value, the role of biomarkers in primary graft dysfunction has been less thoroughly explored.
We will try in this study de determine the rule of pneumoproteins in the donor organ on the pulmonary edema in the recipient.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
20
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Namur
-
Yvoir, Namur, Belgium, 5530
- CHU Mont-Godinne
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 70 years (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Organ donors and lung recipients
Description
Inclusion Criteria:
All the organ donors for lung grafts.
Exclusion Criteria:
none
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
NHBD
Non Heart Beating Donors
|
|
BDD
Brain death donors
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of Recipient with primary graft dysfunction
Time Frame: one year
|
one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (ACTUAL)
January 1, 2016
Study Completion (ACTUAL)
January 1, 2016
Study Registration Dates
First Submitted
January 6, 2014
First Submitted That Met QC Criteria
January 8, 2014
First Posted (ESTIMATE)
January 9, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
March 15, 2016
Last Update Submitted That Met QC Criteria
March 13, 2016
Last Verified
March 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B406201112693
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Primary Graft Dysfunction
-
Apeptico Forschung und Entwicklung GmbHCompletedPGD Primary Graft DysfunctionAustria
-
University Hospital, Strasbourg, FranceCompletedPrimary Lung Graft DysfunctionFrance
-
Loma Linda UniversityWithdrawnLiver Graft Dysfunction
-
University Hospital TuebingenCompletedIntestinal Graft DysfunctionGermany
-
Assistance Publique Hopitaux De MarseilleNot yet recruiting
-
University of OklahomaUniversity of Michigan; Emory UniversityRecruitingPrimary Graft FailureUnited States
-
University Health Network, TorontoToronto General HospitalUnknownPrimary Graft DysfunctionCanada
-
University Hospital, Strasbourg, FranceUnknownPrimary Graft DysfunctionFrance
-
University Hospital, Strasbourg, FranceUnknownPrimary Graft DysfunctionFrance
-
Gladwin, Mark, MDTerminatedPrimary Graft DysfunctionUnited States
Clinical Trials on no intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Medical Corps, Israel Defense ForceUnknownMusculoskeletal Disorders | Upper Extremity Pain ChronicIsrael